Learn more →
Back to Expert Scholars
gi-oncology / gi-oncologyGastric Cancer

Daniel Coit

丹尼尔·科伊特

MD, FACS

🏢Memorial Sloan Kettering Cancer Center(纪念斯隆-凯特琳癌症中心)🌐USA

Attending Surgeon, Gastric and Mixed Tumor Service胃肿瘤外科主治医师

49
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Dr. Daniel Coit is a preeminent gastric cancer surgeon at MSKCC with decades of experience in radical gastrectomy and peritoneal disease management. His research on staging, lymphadenectomy extent, and multidisciplinary care has shaped surgical guidelines internationally.

Share:

🧪Research Fields 研究领域

Surgical Oncology外科肿瘤学
Gastric Cancer胃癌
Peritoneal Metastases腹膜转移
Staging分期

🎓Key Contributions 主要贡献

Gastric Cancer Staging and Lymphadenectomy

Defined optimal lymph node dissection extent for gastric cancer in Western populations, clarifying the survival benefit of D2 resection.

Peritoneal Metastases Management

Advanced cytoreductive surgery and hyperthermic intraperitoneal chemotherapy approaches for gastric cancer with peritoneal spread.

Representative Works 代表性著作

[1]

Sentinel lymph node mapping in gastric cancer: a prospective validation study

Annals of Surgical Oncology (2019)

Validated sentinel node techniques for early gastric cancer, enabling function-preserving surgery in select patients.

[2]

Impact of extended lymphadenectomy on survival in resectable gastric cancer

Annals of Surgery (2018)

Provided long-term outcome data clarifying the role of D2 dissection in gastric cancer surgery at a high-volume Western center.

🏆Awards & Recognition 奖项与荣誉

🏆Society of Surgical Oncology Lifetime Achievement Award
🏆MSKCC Outstanding Faculty Award
🏆James Ewing Society Distinguished Member

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 丹尼尔·科伊特 的研究动态

Follow Daniel Coit's research updates

留下邮箱,当我们发布与 Daniel Coit(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment